Clinical Trials Sponsored by Radiotherapie

Total 59 results

Radiotherapie

Completed

Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma

Melanoma | Effects of Immunotherapy | Adverse Effect of Radiation Therapy

Belgium
Groupe Oncologie Radiotherapie Tete et Cou

Recruiting

Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck (AdCC_2023-01)

Adenoid Cystic Carcinoma of the Head and Neck

France
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Comparison of Two Concomitant Administration of RT With Cisplatin in Standard Infusion or Fractional Infusion (CisFRad)

Squamous Cell Carcinoma of the Head and Neck

France
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Evaluation of the Tolerance of Afatinib in Combination With Docetaxel and Cisplatin in LAHNSCC Induction Chemotherapy (TAPIS)

HNSCC

France
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Reirradiation and Erbitux in the HNSCC

Head and Neck Cancer Squamous Cell

France
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC

Oral Cancer | Oropharynx Cancer | Larynx Cancer | Hypopharynx Cancer

France
Groupe Oncologie Radiotherapie Tete et Cou

Recruiting

Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Cancer (XXL_2022-01)

Squamous Cell Carcinoma of the Head and Neck

France
Groupe Oncologie Radiotherapie Tete et Cou

Active, not recruiting

Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT (SALTORL)

Head and Neck Squamous Cell Carcinoma

France
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC (PembroRad)

Squamous Cell Carcinoma of the Head and Neck

France
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux (2007-01)

HNSCC

France
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. (2007/02)

Squamous Cell Head and Neck Carcinoma

France
Groupe Oncologie Radiotherapie Tete et Cou

Terminated

Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers (NPC2006)

Nasopharyngeal Cancers

France, Tunisia, Morocco, Romania
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux® (GORTEC 2009-01)

Head and Neck Carcinoma

France
Groupe Oncologie Radiotherapie Tete et Cou

Active, not recruiting

Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC (OMET)

Head and Neck Squamous Cell Carcinoma

France
Groupe Oncologie Radiotherapie Tete et Cou

Completed

IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC

Oral Cancer | Oropharynx Cancer | Hypopharynx Cancer

France
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol (OTOHTPF)

Squamous Cell Head and Neck Carcinoma

France
Groupe Oncologie Radiotherapie Tete et Cou
AstraZeneca

Terminated

Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas

Head and Neck Cancer

France
Groupe Oncologie Radiotherapie Tete et Cou
UNICANCER

Active, not recruiting

Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH) (REACH)

HNSCC

France
Groupe Oncologie Radiotherapie Tete et Cou
Sanofi

Completed

Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma

Larynx Cancer | Hypopharynx Cancer

France
Sanofi
Groupe Oncologie Radiotherapie Tete et Cou

Completed

TRACE: Tirapazamine-Radiation And Cisplatin Evaluation (TRACE)

Head and Neck Squamous Cell Carcinoma

United States, France, Canada, Poland, Germany, Spain, Switzerland, Singapore, Taiwan, Argentina, Hungary, Italy, Chile, Hong Kong, South Africa, Australia, New Zealand
Groupe Oncologie Radiotherapie Tete et Cou
Schering-Plough

Completed

Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas

Head and Neck Cancer

France
Groupe Oncologie Radiotherapie Tete et Cou
Centre Leon Berard

Active, not recruiting

Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma (TPFmORL)

Cancer of Head and Neck

France
Institute of Radiotherapy and Oncology, Macedonia

Completed

Altered and Conventional Fractionated Radiotherapy in Patients With Head and Neck Cancer

Head and Neck Cancer
Groupe Oncologie Radiotherapie Tete et Cou
For Drug Consulting; Eurofins

Recruiting

A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck (NIVOPOSTOP)

Squamous Cell Carcinoma of Head and Neck

France
Groupe Oncologie Radiotherapie Tete et Cou
National Cancer Institute, France

Recruiting

Chemo-radiotherapy Versus Radiotherapy in the Treatment of Salivary Glands and Nasal Tumors (IMRT or Protontherapy) (SANTAL)

HNSCC

France
Groupe Oncologie Radiotherapie Tete et Cou
UNICANCER; Center Eugene Marquis

Active, not recruiting

Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN (REWRITe)

HNSCC

France
Grupo de Investigación Clínica en Oncología Radioterapia

Completed

OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL) (OPTIMAL)

Breast Cancer

Spain, Portugal, Italy
Grupo de Investigación Clínica en Oncología Radioterapia

Recruiting

Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate Carcinoma

Prostate Cancer

Spain
Grupo de Investigación Clínica en Oncología Radioterapia

Completed

Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer

Oligometastatic Prostate Cancer

Spain
Grupo de Investigación Clínica en Oncología Radioterapia

Terminated

OPTimizing Irradiation Through Molecular Assesment of Lymph Node After Primary Systemic Treatment (OPTIMALIIa)

Breast Cancer

Spain
Grupo de Investigación Clínica en Oncología Radioterapia

Completed

Memory Preservation of Prophylactic Cranial Irradiation With Hippocampal Avoidance (PREMER-TRIAL)

Small Cell Lung Carcinoma

Spain
Grupo de Investigación Clínica en Oncología Radioterapia

Unknown

Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

Spain
International Geriatric Radiotherapy Group
Brigitta G. Baumert

Unknown

Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis

COVID-19 Pneumonitis
Grupo de Investigación Clínica en Oncología Radioterapia

Completed

Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of the Head and Neck

Spain
Grupo de Investigación Clínica en Oncología Radioterapia

Completed

N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation

Chemoradiation | Surgery | Survival | Non-small-Cell Lung Carcinoma | Stage IIIA-N2

Spain
Grupo de Investigación Clínica en Oncología Radioterapia

Completed

Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis (CP073)

Head and Neck Cancer | Chemotherapy | Mucositis | Breakthrough Pain | Radiotherapy

Spain
Grupo de Investigación Clínica en Oncología Radioterapia
Norgine

Recruiting

Clinical Study Assessing the Effect of ZIVEREL® in Cancer Patients

Acute Esophagitis

Spain
Groupe Oncologie Radiotherapie Tete et Cou
Tumor Study Group Head and Neck

Completed

Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation

Larynx Cancer | Hypopharynx Cancer

France
Groupe Oncologie Radiotherapie Tete et Cou
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC (ELAN-RT)

Head and Neck Squamous Cell Carcinoma

France, Monaco
Groupe Oncologie Radiotherapie Tete et Cou
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (TPEx)

Squamous Cell Head and Neck Carcinoma | Recurrent or Metastatic Disease

France, Belgium
Groupe Oncologie Radiotherapie Tete et Cou
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC (ELANFIT)

Metastatic or Recurrent Head and Neck Squamous Cell Cancer

France
AHS Cancer Control Alberta
IGAR Image guided adaptive radiotherapy

Completed

A Feasibility Study to Compare the Benefits of Endoscopic Tumor Clip Placement and 3T-MRI Simulation for Accurate Target Volume Definition for Rectal Cancer Patients Undergoing Pre-operative Chemoradiation

Rectal Cancer

Canada
University College, London
Cancer Research UK; NCRI Radiotherapy Trials QA (RTTQA) Group

Completed

A Study of IMRT in Primary Bone and Soft Tissue Sarcoma (IMRiS)

Ewing Sarcoma | Chordoma | Bone Sarcoma | Soft Tissue Sarcoma, Adult

United Kingdom, Ireland
Groupe Oncologie Radiotherapie Tete et Cou
AIO-Studien-gGmbH; Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Completed

Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC (TPExtreme)

Head and Neck Squamous Cell Carcinoma

France, Germany, Spain
Radiotherapy Oncology Centre "Santa Maria" Hospital
Paola Anselmo,MD; Michelina Casale,PhD; Fabio Trippa,MD

Recruiting

Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer (STARTNEWERA-OM)

NSCLC | Non Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | Oligometastatic Disease | Non-Small Cell Squamous Lung Cancer | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor | Non-Small Cell Adenocarcinoma and other conditions

Italy
Maastricht Radiation Oncology
Heidelberg University; University of Giessen; University Medical Center Nijmegen and other collaborators

Completed

ROCOCO - Low Grade Glioma - Planning Study (ROCOCO LGG)

Low Grade Glioma

Germany, Netherlands
Radiotherapy Oncology Centre "Santa Maria" Hospital
Paola Anselmo,MD; Michelina Casale,PhD; Ernesto Maranzano,MD; Fabio Trippa,MD

Completed

Stereotactic Ablative Radiotherapy in Locally Advanced Non Small Cell Lung Cancer (START-NEW-ERA)

Locally Advanced Lung Non-Small Cell Carcinoma

Italy
Federation Francophone de Cancerologie Digestive
European Organisation for Research and Treatment of Cancer - EORTC; UNICANCER; GERCOR - Multidisciplinary Oncology Cooperative Group and other collaborators

Completed

Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer

Esophageal Cancer

France, Belgium, Netherlands, Germany
Grupo de Investigación Clínica en Oncología Radioterapia
Hospital del Mar; Hospital Universitari Sant Joan de Reus; Hospital Universitario...

Recruiting

Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19

Pneumonia, Viral

Spain
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...

Active, not recruiting

A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

Squamous Cell Carcinoma of the Head and Neck

United States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more

Clinical Trials Sponsored by Radiotherapie

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations